These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8259071)

  • 1. Ocular involvement correlated with age in patients affected by major and intermedia beta-thalassemia treated or not with desferrioxamine.
    Rinaldi M; Della Corte M; Ruocco V; D'Onofrio C; Zanotta G; Romano A
    Metab Pediatr Syst Ophthalmol (1985); 1993; 16(1-2):23-5. PubMed ID: 8259071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular findings in beta-thalassemia.
    Sorcinelli R; Sitzia A; Figus A; Lai ME
    Metab Pediatr Syst Ophthalmol (1985); 1990; 13(1):23-5. PubMed ID: 2370833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular abnormalities in patients with beta thalassemia.
    Gartaganis S; Ismiridis K; Papageorgiou O; Beratis NG; Papanastasiou D
    Am J Ophthalmol; 1989 Dec; 108(6):699-703. PubMed ID: 2596550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of vision associated with angioid streaks in beta-thalassemia intermedia.
    Aessopos A; Floudas CS; Kati M; Tsironi M; Giakoumi X; Livir-Rallatos C; Farmakis D
    Int J Hematol; 2008 Jan; 87(1):35-8. PubMed ID: 18224411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple transfused thalassemia major: ocular manifestations in a hospital-based population.
    Taneja R; Malik P; Sharma M; Agarwal MC
    Indian J Ophthalmol; 2010; 58(2):125-30. PubMed ID: 20195035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: our experience.
    Jethani J; Marwah K; ; Patel S; Shah B
    Indian J Ophthalmol; 2010; 58(5):451-2. PubMed ID: 20689215
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
    Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of ocular alterations in patients with β-thalassemia syndromes suggests a pathology similar to pseudoxanthoma elasticum.
    Barteselli G; Dell'arti L; Finger RP; Charbel Issa P; Marcon A; Vezzola D; Mapelli C; Cassinerio E; Cappellini MD; Ratiglia R; Viola F
    Ophthalmology; 2014 Mar; 121(3):709-18. PubMed ID: 24314836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Thalassemia and ocular implications: a systematic review.
    Liaska A; Petrou P; Georgakopoulos CD; Diamanti R; Papaconstantinou D; Kanakis MG; Georgalas I
    BMC Ophthalmol; 2016 Jul; 16():102. PubMed ID: 27390837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].
    Cario H; Stahnke K; Kohne E
    Klin Padiatr; 1999; 211(6):431-7. PubMed ID: 10592921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.
    Economou M; Printza N; Teli A; Tzimouli V; Tsatra I; Papachristou F; Athanassiou-Metaxa M
    Acta Haematol; 2010; 123(3):148-52. PubMed ID: 20185899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful recovery of acute hemosiderotic heart failure in beta-thalassemia major treated with a combined regimen of desferrioxamine and deferiprone.
    Tavecchia L; Masera N; Russo P; Cirò A; Vincenzi A; Vimercati C; Masera G
    Haematologica; 2006 Jun; 91(6 Suppl):ECR19. PubMed ID: 16785138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on the effect of desferrioxamine B in patients with Cooley's disease].
    Silvestroni E; Bianco I; Masi M
    Policlinico Prat; 1967 Dec; 74(50):1681-90. PubMed ID: 4240868
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.
    Maggio A; Vitrano A; Capra M; Cuccia L; Gagliardotto F; Filosa A; Magnano C; Rizzo M; Caruso V; Gerardi C; Argento C; Campisi S; Cantella F; Commendatore F; D'Ascola DG; Fidone C; Ciancio A; Galati MC; Giuffrida G; Cingari R; Giugno G; Lombardo T; Prossomariti L; Malizia R; Meo A; Roccamo G; Romeo MA; Violi P; Cianciulli P; Rigano P
    Blood Cells Mol Dis; 2009; 42(3):247-51. PubMed ID: 19233692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral contracting to improve adherence in patients with thalassemia.
    Koch DA; Giardina PJ; Ryan M; MacQueen M; Hilgartner MW
    J Pediatr Nurs; 1993 Apr; 8(2):106-11. PubMed ID: 8509968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audiological evaluation in adult beta-thalassemia major patients under regular chelation treatment.
    Ambrosetti U; Dondè E; Piatti G; Cappellini MD
    Pharmacol Res; 2000 Nov; 42(5):485-7. PubMed ID: 11023713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS; Aminasnafi A; Moghadassian H; Gachkar L; Arzanian MT; Alavi S; Esfehani H; Garallahi F; Amini R
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia.
    Hartman C; Tamary H; Tamir A; Shabad E; Levine C; Koren A; Shamir R
    J Pediatr; 2002 Oct; 141(4):543-7. PubMed ID: 12378195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.